Cellebrite DI Ltd. (CLBT)
Cellebrite DI Ltd. (CLBT) Hit a 52 Week High, Can the Run Continue?
Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future?
Are Business Services Stocks Lagging Cellebrite DI Ltd. (CLBT) This Year?
Here is how Cellebrite DI Ltd. (CLBT) and Nexxen International Ltd.
Cellebrite: Rating Downgrade As Valuation Has Caught Up
Cellebrite's 2Q24 results exceeded expectations with solid revenue growth and profit metrics. Progress in key metrics and initiatives indicate potential for >20% growth in the future. CLBT's Valuation has caught up, making the upside less attractive despite a positive fundamental outlook.
Why Cellebrite DI Ltd. (CLBT) Might be Well Poised for a Surge
Cellebrite DI Ltd. (CLBT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year?
Here is how Cellebrite DI Ltd. (CLBT) and Genpact (G) have performed compared to their sector so far this year.
Cellebrite DI Ltd. (CLBT) Soars to 52-Week High, Time to Cash Out?
Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future?
Cellebrite DI Ltd. (CLBT) Q2 2024 Earnings Call Transcript
Cellebrite DI Ltd. (NASDAQ:CLBT ) Q2 2024 Earnings Conference Call August 15, 2024 8:30 AM ET Company Participants Andrew Kramer - IR Yossi Carmil - CEO Dana Gerner - CFO Conference Call Participants Brad Zelnick - Deutsche Bank Mike Cikos - Needham Eric Martinuzzi - Lake Street Shaul Eyal - TD Cowen Jeff Van Rhee - Craig-Hallum Brian Essex - JPMorgan Louie DiPalma - William Blair Tomer Zilberman - Bank of America Operator Welcome to the Cellebrite Second Quarter 2024 Financial Results Conference Call.
Cellebrite DI Ltd. (CLBT) Tops Q2 Earnings and Revenue Estimates
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.08 per share.
Cellebrite DI Ltd. (CLBT) Hits Fresh High: Is There Still Room to Run?
Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future?
Cellebrite DI Ltd. (CLBT) Soars 6.1%: Is Further Upside Left in the Stock?
Cellebrite DI Ltd. (CLBT) witnessed a jump in share price last session on above-average trading volume.
Cellebrite: Very Strong Competitive Advantage That Is Hard To Replicate
Cellebrite has a strong competitive advantage as the gold standard in digital forensics, making it difficult for new players to replicate or displace. CLBT serves a mission-critical function in digital investigations for law enforcement, with a majority of revenue coming from subscriptions. Up/cross selling opportunities and penetration into adjacent functions are key drivers for CLBT's future earnings growth.
Cellebrite DI Ltd. (CLBT) Q1 2024 Earnings Call Transcript
Cellebrite DI Ltd. (NASDAQ:CLBT ) Q1 2024 Earnings Call Transcript May 23, 2024 8:30 AM ET Company Participants Andrew Kramer - IR Yossi Carmil - CEO Dana Gerner - CFO Conference Call Participants Shaul Eyal - TD Cowen Jonathan Ho - William Blair Mike Cikos - Needham Eric Martinuzzi - Lake Street Brian Essex - JPMorgan Jeff Van Rhee - Craig-Hallum Louie DiPalma - William Blair Tomer Zilberman - Bank of America Operator Welcome to the Cellebrite First Quarter 2024 Financial Results Conference Call.
